Ibogaine Safety
Ibogaine Safety
- 12 lead ECG (stress echocardiogram in the case of abnormalities)
- Comprehensive metabolic panel
- Kidney function (including BUN – blood/urea/nitrogen levels
- Liver function (including Albumin, AST, ALT, GGT)
- Serum electrolytes (sodium, potassium, ionized calcium, magnesium, protein & glucose)
- Complete blood count (including white blood count, haemoglobin, haematocrit, and platelet count)
- Thyroid function (only if you are above 45 years of age)
- We will also require that you be completely free of stimulants (including coffee) and not in withdrawal at the time of testing.
Clare S. Wilkins, a founder of Pangea Biomedics, and has collaborated with the Multidisciplinary Association for Psychedelic Studies (MAPS) in the seminal Mexico study, and through her work has facilitated over 700 ibogaine treatments.
Although she was once an intravenous drug user, who transitioned to methadone, and was then freed of her addiction by ibogaine; she has been an active board member of the Global Ibogaine Therapy Alliance (GITA) since 2010 and is currently collaborating with the International Centre for Ethnobotanical Education, Research and Service (ICEERS) to develop clinical trials for an ibogaine assisted detox to successfully get people off methadone.
Individuals taking antipsychotics and antidepressants are automatically excluded. It is advisable to do much research on the issue, independently of what your centre of choice tells you, and a trusted source would be the Ibogaine Safety Guidelines.
Tackling the considerable misinformation surrounding ibogaine and benzodiazepines, Wilkins sets the record straight, saying that ibogaine is not as effective for benzos as it is for opioids or stimulants (for more in-depth information about tapering off benzodiazepines before considering an ibogaine treatment, patients should refer to the Heather Ashton manual.)
- 12 lead ECG (stress echocardiogram in the case of abnormalities)
- Comprehensive metabolic panel
- Kidney function (including BUN – blood/urea/nitrogen levels
- Liver function (including Albumin, AST, ALT, GGT)
- Serum electrolytes (sodium, potassium, ionized calcium, magnesium, protein & glucose)
- Complete blood count (including white blood count, haemoglobin, haematocrit, and platelet count)
- Thyroid function (only if you are above 45 years of age)
- We will also require that you be completely free of stimulants (including coffee) and not in withdrawal at the time of testing.
Clare S. Wilkins, a founder of Pangea Biomedics, and has collaborated with the Multidisciplinary Association for Psychedelic Studies (MAPS) in the seminal Mexico study, and through her work has facilitated over 700 ibogaine treatments.
Although she was once an intravenous drug user, who transitioned to methadone, and was then freed of her addiction by ibogaine; she has been an active board member of the Global Ibogaine Therapy Alliance (GITA) since 2010 and is currently collaborating with the International Centre for Ethnobotanical Education, Research and Service (ICEERS) to develop clinical trials for an ibogaine assisted detox to successfully get people off methadone.
Individuals taking antipsychotics and antidepressants are automatically excluded. It is advisable to do much research on the issue, independently of what your centre of choice tells you, and a trusted source would be the Ibogaine Safety Guidelines.
Tackling the considerable misinformation surrounding ibogaine and benzodiazepines, Wilkins sets the record straight, saying that ibogaine is not as effective for benzos as it is for opioids or stimulants (for more in-depth information about tapering off benzodiazepines before considering an ibogaine treatment, patients should refer to the Heather Ashton manual.)